Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design (2013)
- Authors:
- USP affiliated authors: TAQUEDA, MARIA ELENA SANTOS - EP ; BABY, ANDRÉ ROLIM - FCF ; KANEKO, TELMA MARY - FCF ; VELASCO, MARIA VALERIA ROBLES - FCF ; CONSIGLIERI, VLADI OLGA - FCF
- Unidades: EP; FCF
- DOI: 10.3109/10837450.2012.693508
- Subjects: COMPRIMIDOS; CELULOSE; FÁRMACOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Pharmaceutical Development and Technology
- ISSN: 1083-7450
- Volume/Número/Paginação/Ano: v. 18, n. 5, p. 1247-1254, 2013
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
DUQUE, Marcelo Dutra et al. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design. Pharmaceutical Development and Technology, v. 18, n. 5, p. 1247-1254, 2013Tradução . . Disponível em: https://doi.org/10.3109/10837450.2012.693508. Acesso em: 25 fev. 2026. -
APA
Duque, M. D., Kreidel, R. N., Taqueda, M. E. S., Baby, A. R., Kaneko, T. M., Velasco, M. V. R., & Consiglieri, V. O. (2013). Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design. Pharmaceutical Development and Technology, 18( 5), 1247-1254. doi:10.3109/10837450.2012.693508 -
NLM
Duque MD, Kreidel RN, Taqueda MES, Baby AR, Kaneko TM, Velasco MVR, Consiglieri VO. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design [Internet]. Pharmaceutical Development and Technology. 2013 ; 18( 5): 1247-1254.[citado 2026 fev. 25 ] Available from: https://doi.org/10.3109/10837450.2012.693508 -
Vancouver
Duque MD, Kreidel RN, Taqueda MES, Baby AR, Kaneko TM, Velasco MVR, Consiglieri VO. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design [Internet]. Pharmaceutical Development and Technology. 2013 ; 18( 5): 1247-1254.[citado 2026 fev. 25 ] Available from: https://doi.org/10.3109/10837450.2012.693508 - Optimization of poorly compactable drug tablets manufactured by direct compression using the mixture experimental design
- Hydrating effects of moisturizer active compounds incorporated into hydrogels: in vivo assessment and comparison between devices
- Avaliação clínica in vitro da perda de água transepidérmica e comparação entre equipamentos
- Assessment of in vitro sun protection factor (SPF) and rheological profile of commercial infant sunscreens
- Development and physicochemical stability of "non-sulfated" surfactant formulations
- Desenvolvimento e teste preliminar da estabilidade de formulações cosméticas acrescidas de extrato comercial de Trichilia catigua Adr. Juss (e) Ptychopetalum olacoides Bentham
- Protein based nanotechnology: Antioxidant and photoprotection activities
- In vitro sun protection factor (spf) of commercial sunscreens by reflectance spectrophotometry
- Evaluation of hair damage after treatments with light brown and light blond permanent dyes: Hair protein loss determination
- Development and in vitro photoprotection efficacy of bioactive sunscreens containing rutin, avobenzone and octyl dimethyl paba
Informações sobre o DOI: 10.3109/10837450.2012.693508 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
